Insmed
INSM
#1119
Rank
A$30.24 B
Marketcap
A$139.53
Share price
3.07%
Change (1 day)
-11.00%
Change (1 year)

Market capitalization of Insmed (INSM)

Market cap: A$30.24 Billion

As of June 2026 Insmed has a market cap of A$30.24 Billion. This makes Insmed the world's 1119th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Insmed from 2000 to 2026

End of year Market Cap

Year Marketcap Change
2026A$30.24 B-46.6%
2025A$56.63 B182.89%
2024A$20.02 B207.67%
2023A$6.50 B63.6%
2022A$3.97 B-10.57%
2021A$4.44 B0.85%
2020A$4.41 B44.18%
2019A$3.05 B112.45%
2018A$1.43 B-52.93%
2017A$3.05 B169.34%
2016A$1.13 B-26.26%
2015A$1.54 B63.58%
2014A$0.94 B26.22%
2013A$0.74 B267.97%
2012A$0.20 B174.42%
2011A$73.86 M-24.01%
2010A$97.21 M-12.9%
2009A$0.11 B37.7%
2008A$81.05 M-29.54%
2007A$0.11 B1.7%
2006A$0.11 B-36.85%
2005A$0.17 B40.4%
2004A$0.12 B-16.85%
2003A$0.15 B480.07%
2002A$26.44 M-89.27%
2001A$0.24 B21.13%
2000A$0.20 B

End of Day market cap according to different sources

On Jun 16th, 2026 the market cap of Insmed was reported to be:

A$29.34 Billion
by Nasdaq info icon info icon
A$29.34 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Novartis
NVS
A$408.03 B 1,249.12%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Gilead Sciences
GILD
A$220.75 B 629.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
A$165.10 B 445.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
A$2.53 B-91.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
A$1.06 B-96.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Array Technologies
ARRY
A$1.67 B-94.48%๐Ÿ‡บ๐Ÿ‡ธ USA